Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial
Huabin Hu(Sun Yat-sen University), Yanhong Deng(Sun Yat-sen University), Weihao Deng(Sun Yat-sen University), Zehua Wu(Shanghai Jiao Tong University), Ruoxu Dou(General Hospital of Guangzhou Military Command), Jiancong Hu(Sun Yat-sen University), Xiaoyu Xie(Sun Yat-sen University), Cailu Shen(Sun Yat-sen University), Jiayu Ling(Sun Yat-sen University), Yue Cai(Sun Yat-sen University), Yan Huang(Sun Yat-sen University), Lishuo Shi(Sun Yat-sen University), Meijin Huang(Sun Yat-sen University), Tenghui Ma(Sun Yat-sen University), Liang Kang(Sun Yat-sen University), Jianwei Zhang(Capital Medical University), Chao Wang(Unknown), Li Ling(Xinjiang Academy of Forestry), Hao Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Hui Wang(Sun Yat-sen University), Xingwei Zhang(Affiliated Hospital of Hangzhou Normal University), Yonghua Cai(Sun Yat-sen University), Xiaojian Wu(Guangxi Academy of Agricultural Science), Liang Huang(Sun Yat-sen University), Jiaming Zhou(Sun Yat-sen University), Huaiming Wang(Sun Yat-sen University), Xiaowen He(Hong Kong Polytechnic University), Shuangling Luo(Sun Yat-sen University), Wuteng Cao(Sun Yat-sen University), Ping Lan(Sun Yat-sen University)
Cited by 304
Related Papers
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2021|4.3k
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2023|892
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
|Clinical Cancer Research|2018|456